CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis is a research paper published in Immunity (2020). On theSindex it has a DataRank of 6.7. It has been cited 248 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.828
From this paper's citation signal
Citation Network Contribution
5.8
From 182 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
National Institutes of Health
Grant: F32GM120990
NIGMS NIH HHS
Grant: T32 GM008284
National Institute of General Medical Sciences
Howard Hughes Medical Institute
Howard Hughes Medical Institute
FWCI
8.38
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study
Additional file 1 of Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study
Additional file 1 of Targeting HDAC6 improves anti-CD47 immunotherapy
Additional file 1 of Targeting HDAC6 improves anti-CD47 immunotherapy
Additional file 1 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 1 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 6 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 6 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 2 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 4 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 3 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 2 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 5 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 3 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 4 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
Additional file 5 of BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma